Cargando…

S146: GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR (CBTKI) PRE-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY

Detalles Bibliográficos
Autores principales: Brown, Jennifer R., Desikan, Sai Prasad, Nguyen, Bastien, Won, Helen, Tantawy, Shady, Mcneely, Samuel Clark, Marella, Narasimha, Ebata, Kevin, Woyach, Jennifer, Patel, Krish, Tam, Constantine, Eyre, Toby, Cheah, Chan, Shah, Nirav N, Ghia, Paolo, Jurczak, Wojciech, Balbas, Minna, Nair, Binoj, Abada, Paolo, Wang, Chunxiao, Wang, Denise, Mato, Anthony R., Gandhi, Varsha, Wierda, William G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428413/
http://dx.doi.org/10.1097/01.HS9.0000967496.62332.46
_version_ 1785090463111315456
author Brown, Jennifer R.
Desikan, Sai Prasad
Nguyen, Bastien
Won, Helen
Tantawy, Shady
Mcneely, Samuel Clark
Marella, Narasimha
Ebata, Kevin
Woyach, Jennifer
Patel, Krish
Tam, Constantine
Eyre, Toby
Cheah, Chan
Shah, Nirav N
Ghia, Paolo
Jurczak, Wojciech
Balbas, Minna
Nair, Binoj
Abada, Paolo
Wang, Chunxiao
Wang, Denise
Mato, Anthony R.
Gandhi, Varsha
Wierda, William G.
author_facet Brown, Jennifer R.
Desikan, Sai Prasad
Nguyen, Bastien
Won, Helen
Tantawy, Shady
Mcneely, Samuel Clark
Marella, Narasimha
Ebata, Kevin
Woyach, Jennifer
Patel, Krish
Tam, Constantine
Eyre, Toby
Cheah, Chan
Shah, Nirav N
Ghia, Paolo
Jurczak, Wojciech
Balbas, Minna
Nair, Binoj
Abada, Paolo
Wang, Chunxiao
Wang, Denise
Mato, Anthony R.
Gandhi, Varsha
Wierda, William G.
author_sort Brown, Jennifer R.
collection PubMed
description
format Online
Article
Text
id pubmed-10428413
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104284132023-08-17 S146: GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR (CBTKI) PRE-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY Brown, Jennifer R. Desikan, Sai Prasad Nguyen, Bastien Won, Helen Tantawy, Shady Mcneely, Samuel Clark Marella, Narasimha Ebata, Kevin Woyach, Jennifer Patel, Krish Tam, Constantine Eyre, Toby Cheah, Chan Shah, Nirav N Ghia, Paolo Jurczak, Wojciech Balbas, Minna Nair, Binoj Abada, Paolo Wang, Chunxiao Wang, Denise Mato, Anthony R. Gandhi, Varsha Wierda, William G. Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428413/ http://dx.doi.org/10.1097/01.HS9.0000967496.62332.46 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Oral Sessions
Brown, Jennifer R.
Desikan, Sai Prasad
Nguyen, Bastien
Won, Helen
Tantawy, Shady
Mcneely, Samuel Clark
Marella, Narasimha
Ebata, Kevin
Woyach, Jennifer
Patel, Krish
Tam, Constantine
Eyre, Toby
Cheah, Chan
Shah, Nirav N
Ghia, Paolo
Jurczak, Wojciech
Balbas, Minna
Nair, Binoj
Abada, Paolo
Wang, Chunxiao
Wang, Denise
Mato, Anthony R.
Gandhi, Varsha
Wierda, William G.
S146: GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR (CBTKI) PRE-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY
title S146: GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR (CBTKI) PRE-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY
title_full S146: GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR (CBTKI) PRE-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY
title_fullStr S146: GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR (CBTKI) PRE-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY
title_full_unstemmed S146: GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR (CBTKI) PRE-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY
title_short S146: GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR (CBTKI) PRE-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY
title_sort s146: genomic evolution and resistance to pirtobrutinib in covalent btk-inhibitor (cbtki) pre-treated chronic lymphocytic leukemia (cll) patients: results from the phase i/ii bruin study
topic Oral Sessions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428413/
http://dx.doi.org/10.1097/01.HS9.0000967496.62332.46
work_keys_str_mv AT brownjenniferr s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy
AT desikansaiprasad s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy
AT nguyenbastien s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy
AT wonhelen s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy
AT tantawyshady s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy
AT mcneelysamuelclark s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy
AT marellanarasimha s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy
AT ebatakevin s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy
AT woyachjennifer s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy
AT patelkrish s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy
AT tamconstantine s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy
AT eyretoby s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy
AT cheahchan s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy
AT shahniravn s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy
AT ghiapaolo s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy
AT jurczakwojciech s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy
AT balbasminna s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy
AT nairbinoj s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy
AT abadapaolo s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy
AT wangchunxiao s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy
AT wangdenise s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy
AT matoanthonyr s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy
AT gandhivarsha s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy
AT wierdawilliamg s146genomicevolutionandresistancetopirtobrutinibincovalentbtkinhibitorcbtkipretreatedchroniclymphocyticleukemiacllpatientsresultsfromthephaseiiibruinstudy